292 related articles for article (PubMed ID: 35202123)
1. Olfactory Bulb D
Alberts T; Antipova V; Holzmann C; Hawlitschka A; Schmitt O; Kurth J; Stenzel J; Lindner T; Krause BJ; Wree A; Witt M
Toxins (Basel); 2022 Jan; 14(2):. PubMed ID: 35202123
[TBL] [Abstract][Full Text] [Related]
2. [
Mann T; Kurth J; Hawlitschka A; Stenzel J; Lindner T; Polei S; Hohn A; Krause BJ; Wree A
Molecules; 2018 Mar; 23(3):. PubMed ID: 29509680
[TBL] [Abstract][Full Text] [Related]
3. Dopamine, Noradrenaline and Serotonin Receptor Densities in the Striatum of Hemiparkinsonian Rats following Botulinum Neurotoxin-A Injection.
Mann T; Zilles K; Dikow H; Hellfritsch A; Cremer M; Piel M; Rösch F; Hawlitschka A; Schmitt O; Wree A
Neuroscience; 2018 Mar; 374():187-204. PubMed ID: 29421436
[TBL] [Abstract][Full Text] [Related]
4. Intrastriatal administration of botulinum neurotoxin A normalizes striatal D
Wedekind F; Oskamp A; Lang M; Hawlitschka A; Zilles K; Wree A; Bauer A
J Neurosci Res; 2018 Jan; 96(1):75-86. PubMed ID: 28695985
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson's Disease.
Antipova V; Holzmann C; Hawlitschka A; Witt M; Wree A
Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357977
[TBL] [Abstract][Full Text] [Related]
6. Behavioral and structural effects of unilateral intrastriatal injections of botulinum neurotoxin a in the rat model of Parkinson's disease.
Antipova V; Hawlitschka A; Mix E; Schmitt O; Dräger D; Benecke R; Wree A
J Neurosci Res; 2013 Jun; 91(6):838-47. PubMed ID: 23553727
[TBL] [Abstract][Full Text] [Related]
7. Repeated intrastriatal application of botulinum neurotoxin-A did not influence choline acetyltransferase-immunoreactive interneurons in hemiparkinsonian rat brain - A histological, stereological and correlational analysis.
Hawlitschka A; Berg C; Schmitt O; Holzmann C; Wree A; Antipova V
Brain Res; 2020 Sep; 1742():146877. PubMed ID: 32387181
[TBL] [Abstract][Full Text] [Related]
8. The significance of rotational behavior and sensitivity of striatal dopamine receptors in hemiparkinsonian rats: A comparative study of lactacystin and 6-OHDA.
Konieczny J; Czarnecka A; Lenda T; Kamińska K; Antkiewicz-Michaluk L
Neuroscience; 2017 Jan; 340():308-318. PubMed ID: 27826109
[TBL] [Abstract][Full Text] [Related]
9. Repeated Intrastriatal Botulinum Neurotoxin-A Injection in Hemiparkinsonian Rats Increased the Beneficial Effect on Rotational Behavior.
Hawlitschka A; Holzmann C; Wree A; Antipova V
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208596
[TBL] [Abstract][Full Text] [Related]
10. Pirouetting pigs: A large non-primate animal model based on unilateral 6-hydroxydopamine lesioning of the nigrostriatal pathway.
Christensen AB; Sørensen JCH; Ettrup KS; Orlowski D; Bjarkam CR
Brain Res Bull; 2018 May; 139():167-173. PubMed ID: 29462643
[TBL] [Abstract][Full Text] [Related]
11. Botulinum Neurotoxin A Injected Ipsilaterally or Contralaterally into the Striatum in the Rat 6-OHDA Model of Unilateral Parkinson's Disease Differently Affects Behavior.
Antipova VA; Holzmann C; Schmitt O; Wree A; Hawlitschka A
Front Behav Neurosci; 2017; 11():119. PubMed ID: 28680396
[TBL] [Abstract][Full Text] [Related]
12. Intrastriatal botulinum toxin abolishes pathologic rotational behaviour and induces axonal varicosities in the 6-OHDA rat model of Parkinson's disease.
Wree A; Mix E; Hawlitschka A; Antipova V; Witt M; Schmitt O; Benecke R
Neurobiol Dis; 2011 Feb; 41(2):291-8. PubMed ID: 20955797
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic Lesion in the Olfactory Bulb Restores Olfaction and Induces Depressive-Like Behaviors in a 6-OHDA Model of Parkinson's Disease.
Ilkiw JL; Kmita LC; Targa ADS; Noseda ACD; Rodrigues LS; Dorieux FWC; Fagotti J; Dos Santos P; Lima MMS
Mol Neurobiol; 2019 Feb; 56(2):1082-1095. PubMed ID: 29869198
[TBL] [Abstract][Full Text] [Related]
14. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
[TBL] [Abstract][Full Text] [Related]
15. MT
Noseda ACD; Rodrigues LS; Targa ADS; Ilkiw JL; Fagotti J; Dos Santos PD; Cecon E; Markus RP; Solimena M; Jockers R; Lima MMS
Eur J Pharmacol; 2021 Jan; 891():173722. PubMed ID: 33159932
[TBL] [Abstract][Full Text] [Related]
16. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.
Ahmad M; Saleem S; Ahmad AS; Yousuf S; Ansari MA; Khan MB; Ishrat T; Chaturvedi RK; Agrawal AK; Islam F
J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of D2/D3 receptors increases efficacy of ropinirole in chronically 6-OHDA-lesioned Parkinsonian rats.
Matsukawa N; Maki M; Yasuhara T; Hara K; Yu G; Xu L; Kim KM; Morgan JC; Sethi KD; Borlongan CV
Brain Res; 2007 Jul; 1160():113-23. PubMed ID: 17573046
[TBL] [Abstract][Full Text] [Related]
19. Is nicotine protective against Parkinson's disease? An experimental analysis.
García-Montes JR; Boronat-García A; López-Colomé AM; Bargas J; Guerra-Crespo M; Drucker-Colín R
CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):897-906. PubMed ID: 23131151
[TBL] [Abstract][Full Text] [Related]
20. Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia.
Zhou X; Doorduin J; Elsinga PH; Dierckx RAJO; de Vries EFJ; Casteels C
Neuroimage; 2017 Aug; 157():209-218. PubMed ID: 28583881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
